Effects of tetrazole derivatives on [3H]diazepam binding in vitro: Correlation with convulsant potency

Moshe Rehavi, Phil Skolnick, Steven M. Paul

Research output: Contribution to journalArticlepeer-review

72 Scopus citations


A series of 8 tetrazole derivatives which differ more than one hundred-fold in their potencies as convulsants were tested for their abilities to inhibit [3H]diazepam binding to benzodiazepine receptors in vitro. The concentrations of drug necessary to inhibit 50% of specifically bound [3H]diazepam ranges from 18 μM for undecamethylenetetrazole to 20 mM for trimethylenetetrazole. A comparison of the minimum convulsive doses for the 8 tetrazole derivatives tested with their relative potencies in displacing [3H]diazepam binding in vitro revealed a highly significant correlation (r=0.98, P<0.001). In contrast, several representative tetrazole derivatives were found to have no inhibitory effects on β-adrenergic, α-adrenergic or muscarinic cholinergic receptors in the same membrane preparation. These results suggest that pentamethylenetetrazole and related tetrazole derivatives may elicit their convulsant effects by interaction with the benzodiazepine receptor.

Original languageEnglish
Pages (from-to)353-356
Number of pages4
JournalEuropean Journal of Pharmacology
Issue number3
StatePublished - Mar 12 1982


  • Benzodiazepine receptors
  • Convulsants
  • Pentamethylenetetrazole
  • Tetrazole derivatives


Dive into the research topics of 'Effects of tetrazole derivatives on [3H]diazepam binding in vitro: Correlation with convulsant potency'. Together they form a unique fingerprint.

Cite this